Taurine chloramine inhibits functional responses of human eosinophils in vitro

Clinical and Experimental Allergy

Volumn 39, Issue 4, 2009, Pages 537-546

  Martinez Losa, M ^a   Cortijo, J ^a,b,c   Piqueras, L ^d   Sanz, M J ^a,b   Morcillo, E J ^a,b,d  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c General Universitario   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Apoptosis; Eosinophil cationic protein; Eosinophil peroxidase; Human eosinophils; Leukotriene C4; Superoxide anion; Taurine; Taurine chloramine

Indexed keywords

CALCIUM ION; CYTOCHROME C; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PEROXIDASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 5; LEUKOTRIENE C4; LIPOCORTIN 5; PHORBOL 13 ACETATE 12 MYRISTATE; PROPIDIUM IODIDE; PROTEIN P47; PROTEIN P67; SUPEROXIDE; TAURINE; TAURINE CHLORAMINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG; ZYMOSAN;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL ACTIVATION; CELL ASSAY; CELL FUNCTION; CELL ISOLATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYME RELEASE; EOSINOPHIL; FLOW CYTOMETRY; FLUOROMETRY; HUMAN; HUMAN CELL; IC 50; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; INHIBITION KINETICS; MAGNETIC SEPARATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; SPECTROPHOTOMETRY; WESTERN BLOTTING;

APOPTOSIS; CALCIUM; CELLS, CULTURED; ENZYME INHIBITORS; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-5; LEUKOTRIENE C4; NADPH OXIDASE; NF-KAPPA B; PEROXIDASE; PHOSPHOPROTEINS; RESPIRATORY BURST; SUPEROXIDES; TAURINE;

EID: 62449341306     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03204.x     Document Type: Article

References (50)

1. Sampson AP. The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 2000 30 (Suppl. 1) : 22 7.
2. Henricks PA, Nijkamp FP. Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 2001 14 : 409 20.
3. Barnes PJ. Reactive oxygen species in asthma. Eur Respir Rev 2000 10 : 240 3.
4. Someya A, Nishijima K, Nunoi H, Irie S, Nagaoka I. Study on the superoxide-producing enzyme of eosinophils and neutrophils - comparison of the NADPH oxidase components. Arch Biochem Biophys 1997 345 : 207 13.
5. Wedi B, Straede J, Wieland B, Kapp A. Eosinophil apoptosis is mediated by stimulators of cellular oxidative metabolisms and inhibited by antioxidants: involvement of a thiol-sensitive redox regulation in eosinophil cell death. Blood 1999 94 : 2365 73.
6. Learn DB, Fried VA, Thomas EL. Taurine and hypotaurine content of human leukocytes. J Leukoc Biol 1990 48 : 174 82.
7. Stapleton PP, O'Flaherty L, Redmond HP, Bouchier-Hayes DJ. Host defense - a role for the amino acid taurine? JPEN J Parenter Enteral Nutr 1998 22 : 42 8.
8. Timbrell JA, Seabra V, Waterfield CJ. The in vivo and in vitro protective properties of taurine. Gen Pharmacol 1995 26 : 453 62.
9. Santangelo F, Cortijo J, Morcillo E. Taurine and the lung: which role in asthma? Adv Exp Med Biol 2003 526 : 403 10.
10. Hofford JM, Milakofsky L, Pell S et al. Levels of amino acids and related compounds in bronchoalveolar lavage fluids of asthmatic patients. Am J Respir Crit Care Med 1997 155 : 432 5.
11. Marquez LA, Dunford HB. Chlorination of taurine by myeloperoxidase. Kinetic evidence for an enzyme-bound intermediate. J Biol Chem 1994 269 : 7950 6.
12. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszynska T. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 1995 58 : 667 74.
13. Park E, Schuller-Levis G, Jia JH, Quinn MR. Preactivation exposure of RAW 264.7 cells to taurine chloramine attenuates subsequent production of nitric oxide and expression of iNOS mRNA. J Leukoc Biol. 1997 61 : 161 6.
14. Quinn MR, Park E, Schuller-Levis G. Taurine chloramine inhibits prostaglandin E2 production in activated RAW 264.7 cells by post-transcriptional effects on inducible cyclooxygenase expression. Immunol Lett 1996 50 : 185 8.
15. Park E, Schuller-Levis G, Quinn MR. Taurine chloramine inhibits production of nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 1995 154 : 4778 84.
16. Marcinkiewicz J, Grabowska A, Bereta J, Bryniarski K, Nowak B. Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 1998 40 : 27 38.
17. Kim C, Park E, Quinn MR, Schuller-Levis G. The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-alpha in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 1996 34 : 89 95.
18. Roos D, Eckmann CM, Weiss SJ. Chlorination and bromination reactions by human neutrophils and eosinophils and by their isolated peroxidases. Eur J Clin Invest 1985 15 : A51.
19. Yazdanbakhsh M, Eckmann CM, Roos D. Killing of schistosomula by taurine chloramine and taurine bromamine. Am J Trop Med Hyg 1987 37 : 106 10.
20. Svensson L, Redvall E, Bjorn C et al. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1. Eur J Immunol 2007 37 : 1966 77.
21. Martinez-Losa M, Cortijo J, Juan G, Ramon M, Sanz MJ, Morcillo EJ. Modulatory effects of N-acetyl-L-cysteine on human eosinophil apoptosis. Eur Respir J 2007 30 : 436 42.
22. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968 97 (Suppl.) : 77 89.
23. Hansel TT, De Vries IJ, Iff T et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991 145 : 105 10.
24. Martinez-Losa M, Cortijo J, Juan G et al. Inhibitory effects of N-acetylcysteine on the functional responses of human eosinophils in vitro. Clin Exp Allergy 2007 37 : 714 22.
25. Cortijo J, Villagrasa V, Pons R et al. Bronchodilator and anti-inflammatory activities of glaucine: in vitro studies in human airway smooth muscle and polymorphonuclear leukocytes. Br J Pharmacol 1999 127 : 1641 51.
26. Cortijo J, Villagrasa V, Navarrete C et al. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim. Br J Pharmacol 1996 119 : 99 106.
27. Cortijo J, Pons R, Dasi F et al. Bronchodilator and anti-inflammatory activities of SCA40: studies in human isolated bronchus, human eosinophils, and in the guinea-pig in vivo. Naunyn Schmiedebergs Arch Pharmacol 1997 356 : 806 14.
28. Hatzelmann A, Tenor H, Schudt C. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Br J Pharmacol 1995 114 : 821 31.
29. Buenestado A, Cortijo J, Sanz MJ et al. Olive oil-based lipid emulsion's neutral effects on neutrophil functions and leukocyte-endothelial cell interactions. JPEN J Parenter Enteral Nutr 2006 30 : 286 96.
30. Hallsworth MP, Giembycz MA, Barnes PJ, Lee TH. Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF. Br J Pharmacol 1996 117 : 79 86.
31. Ogino T, Packer L, Maguire JJ. Neutrophil antioxidant capacity during the respiratory burst: loss of glutathione induced by chloramines. Free Radic Biol Med 1997 23 : 445 52.
32. Park E, Jia J, Quinn MR, Schuller-Levis G. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin Immunol 2002 102 : 179 84.
33. Zardini DM, Bueb JL, Tschirhart EJ. Release of O2- by human umbilical cord blood-derived eosinophils: role of intra- and extracellular calcium. Cell Calcium 1999 25 : 381 9.
34. Ward C, Walker A, Dransfield I, Haslett C, Rossi AG. Regulation of granulocyte apoptosis by NF-kappaB. Biochem Soc Trans 2004 32 : 465 7.
35. Hoontrakoon R, Chu HW, Gardai SJ et al. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. Am J Respir Cell Mol Biol 2002 26 : 404 12.
36. 2+ rise. Eur J Clin Invest 1995 25 : 25 31.
37. Babior BM. NADPH oxidase: an update. Blood 1999 93 : 1464 76.
38. Sedgwick JB, Vrtis RF, Gourley MF, Busse WW. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol 1988 81 : 876 83.
39. Choi HS, Cha YN, Kim C. Taurine chloramine inhibits PMA-stimulated superoxide production in human neutrophils perhaps by inhibiting phosphorylation and translocation of p47(phox). Int Immunopharmacol 2006 6 : 1431 40.
40. Munoz NM, Vita AJ, Neeley SP et al. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4. J Pharmacol Exp Ther 1994 268 : 139 43.
41. Bates ME, Green VL, Bertics PJ. ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C(4) biosynthesis. J Biol Chem 2000 275 : 10968 75.
42. Kampen GT, Stafford S, Adachi T et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 2000 95 : 1911 7.
43. Kim C, Choi HS, Kim JW. Taurine chloramine inhibits the production of nitric oxide and superoxide anion by modulating specific mitogen-activated protein kinases. Adv Exp Med Biol 2006 583 : 493 8.
44. Simon HU. Regulation of eosinophil and neutrophil apoptosis-similarities and differences. Immunol Rev 2001 179 : 156 62.
45. Ward C, Dransfield I, Chilvers ER, Haslett C, Rossi AG. Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol Sci 1999 20 : 503 9.
46. Fujihara S, Jaffray E, Farrow SN, Rossi AG, Haslett C, Hay RT. Inhibition of NF-kappa B by a cell permeable form of I kappa B alpha induces apoptosis in eosinophils. Biochem Biophys Res Commun 2005 326 : 632 7.
47. Ward C, Chilvers ER, Lawson MF et al. NF-kappa B activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 1999 274 : 4309 18.
48. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006 107 : 1996 2003.
49. Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, Miyamoto Y. Oxidation of I kappa B alpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J Biol Chem 2002 277 : 24049 56.
50. Tokunaga S, Kanayama A, Miyamoto Y. Modification of I kappa B alpha by taurine bromamine inhibits tumor necrosis factor alpha-induced NF-kappa B activation. Inflamm Res 2007 56 : 479 86.